Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants With 50% or Greater Scalp Hair Loss

NCT06060977 is registered in ClinicalTrials.gov with Inmagene LLC as lead sponsor.

NCT NCT06060977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06060977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants With 50% or Greater Scalp Hair Loss
Lead sponsor
Inmagene LLC
Phase
Phase 1/2
Overall status
Completed
Start date
September 25, 2023
Completion date
January 14, 2025
Enrollment
29 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia areata (aa)